Barclays PLC Boosts Position in Nu Skin Enterprises, Inc. (NYSE:NUS)

Barclays PLC grew its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUSFree Report) by 363.8% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 85,437 shares of the company’s stock after purchasing an additional 67,016 shares during the quarter. Barclays PLC’s holdings in Nu Skin Enterprises were worth $629,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of NUS. Weiss Asset Management LP acquired a new position in shares of Nu Skin Enterprises in the third quarter worth about $2,727,000. Centiva Capital LP bought a new position in shares of Nu Skin Enterprises during the third quarter worth about $508,000. AXA S.A. bought a new stake in Nu Skin Enterprises in the second quarter valued at about $1,061,000. Verition Fund Management LLC bought a new position in Nu Skin Enterprises during the 3rd quarter worth approximately $581,000. Finally, Federated Hermes Inc. lifted its stake in Nu Skin Enterprises by 111.8% during the second quarter. Federated Hermes Inc. now owns 1,323,542 shares of the company’s stock worth $13,950,000 after purchasing an additional 698,722 shares during the last quarter. Hedge funds and other institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Stock Performance

Shares of NYSE NUS opened at $6.89 on Thursday. The stock has a fifty day moving average price of $7.07 and a two-hundred day moving average price of $8.35. Nu Skin Enterprises, Inc. has a 1 year low of $5.95 and a 1 year high of $20.75. The firm has a market cap of $342.51 million, a P/E ratio of -3.33 and a beta of 1.20. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.20 and a current ratio of 1.93.

Nu Skin Enterprises Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 11th. Investors of record on Friday, November 29th were paid a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a yield of 3.48%. The ex-dividend date of this dividend was Friday, November 29th. Nu Skin Enterprises’s dividend payout ratio is presently -11.59%.

Analysts Set New Price Targets

Several research analysts have recently commented on NUS shares. StockNews.com raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Monday, November 11th. DA Davidson cut their price objective on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research report on Friday, December 20th. Finally, Citigroup decreased their price objective on Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating for the company in a report on Tuesday, October 22nd.

Check Out Our Latest Report on Nu Skin Enterprises

About Nu Skin Enterprises

(Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Recommended Stories

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUSFree Report).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.